M.-P. Pagès
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
-
- MicroRNA in disease regulation
Papers in
-
- Acute Myeloid Leukemia Research 3
- Chronic Myeloid Leukemia Treatments 2
- Co-authors
- Y. Bertrand (4 shared papers)Jean-Pierre Rouault (1 shared paper)Gilles Salles (1 shared paper)Martine Ffrench (2 shared papers)Nicole Dastugue (1 shared paper)Judith Landman‐Parker (1 shared paper)Jochen Harbott (1 shared paper)Catherine Léonard (1 shared paper)
In The Last Decade
M.-P. Pagès
14 papers receiving 188 citations
Peers
Comparison fields: 5 of 40
- Hematology 91
- Cancer Research 44
- Public Health, Environmental and Occupational Health 72
- Genetics 16
- Clinical Biochemistry 9
Countries citing papers authored by M.-P. Pagès
This map shows the geographic impact of M.-P. Pagès's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.-P. Pagès with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.-P. Pagès more than expected).
Fields of papers citing papers by M.-P. Pagès
This network shows the impact of papers produced by M.-P. Pagès. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.-P. Pagès. The network helps show where M.-P. Pagès may publish in the future.
Co-authors
The 25 scholars most cited alongside M.-P. Pagès, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 69 | |
| 2 | 2009 | 44 | |
| 3 | 2005 | 22 | |
| 4 | 2004 | 18 | |
| 5 | [Rhabdomyolysis due to simvastin. Apropos of a case with review of the literature]. | 1992 | 12 |
| 6 | Characterization of a t(1;19) pre-B acute lymphoblastic leukemia (ALL) cell line which proliferates in response to IL-7. | 1993 | 11 |
| 7 | 2008 | 8 | |
| 8 | Proliferation of MIELIKI a novel t(7;9) early pre-B acute lymphoblastic leukemia cell line is inhibited concomitantly by IL-4 and IL-7. | 1995 | 5 |
| 9 | 2005 | 2 | |
| 10 | [Benign acute ataxia in an adult with VZV infection]. | 2001 | 1 |
| 11 | [Pituitary tumour as a presenting symptom of a systemic lymphoma]. | 2003 | 1 |
| 12 | [Primary lymphoma of the central nervous system. Multiple remission with corticosteroid therapy]. | 1993 | 1 |
| 13 | [Cleido-cranial dysostosis with malformation of the cervico-occipital junction]. | 1982 | 1 |
| 14 | 2011 | 1 |
About M.-P. Pagès
M.-P. Pagès is a scholar working on Hematology, Neurology, Public Health, Environmental and Occupational Health, Molecular Biology and Oncology, having authored 14 papers that have together received 196 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (4 papers), Acute Myeloid Leukemia Research (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), NF-κB Signaling Pathways (2 papers), MicroRNA in disease regulation (1 paper), Cytokine Signaling Pathways and Interactions (1 paper), Hemoglobinopathies and Related Disorders (1 paper) and Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper). The work is most often cited by research in Hematology (91 citations), Cancer Research (44 citations), Public Health, Environmental and Occupational Health (72 citations), Genetics (16 citations) and Clinical Biochemistry (9 citations). M.-P. Pagès has collaborated with scholars based in France, Poland and Germany. Frequent co-authors include Y. Bertrand, Jean-Pierre Rouault, Gilles Salles, Martine Ffrench, Nicole Dastugue, Judith Landman‐Parker, Jochen Harbott, Catherine Léonard, F Viguié and Judith Bernstein. Their work appears in journals such as Leukemia Research, Leukemia, Bone Marrow Transplantation, Pediatric Blood & Cancer and Archives de Pédiatrie.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.